David J. Endicott Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David J. Endicott.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David J. Endicott. David J. Endicott is a CVP and President, AGN Med in ALLERGAN INC ($AGN) and a Pres., Hospira Medical Devices in HOSPIRA INC ($HSP) and a Director in Orexigen Therapeutics, Inc. ($OREX) and a Director in Zeltiq Aesthetics Inc ($ZLTQ).
Address: 2525 DUPONT DRIVE IRVINE 92612 CA
Companies in which David J. Endicott is an Insider
ALLERGAN INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David J. Endicott: CVP and President, AGN Med
Holdings: 17,335 shares
Current Value: $4,032,294
Latest Transaction: Feb 22 2013
$AGN Market Capitalization: $90.46B
$AGN Previous Close: $232.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HOSPIRA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David J. Endicott: Pres., Hospira Medical Devices
Holdings: 0 shares
Latest Transaction: Sep 03 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Orexigen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David J. Endicott: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 18 2017
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zeltiq Aesthetics Inc
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of David J. Endicott: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 28 2017
$ZLTQ Market Capitalization: $1.85B
$ZLTQ Previous Close: $45.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David J. Endicott
Sentiment: All, AGN, HSP, OREX, ZLTQ
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18 2017 | OREX | Orexigen Therapeut ... | Endicott David J. | Director | Option Exercise | A | 2.88 | 5,000 | 14,400 | 5,000 | |
| Apr 28 2017 | ZLTQ | Zeltiq Aesthetics ... | Endicott David J. | Director | Sell | J | 0.00 | 16,132 | 0 | 0 | 16.1 K to 0 (-100.00 %) |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Endicott David J. | Director | Option Exercise | A | 4.02 | 15,000 | 60,300 | 15,000 | |
| Jun 23 2016 | ZLTQ | Zeltiq Aesthetics ... | Endicott David J. | Director | Grant | A | 28.23 | 6,199 | 174,998 | 16,132 | 9.9 K to 16.1 K (+62.41 %) |
| Apr 26 2016 | ZLTQ | Zeltiq Aesthetics ... | Endicott David J. | Director | Grant | A | 0.00 | 9,933 | 0 | 9,933 | 0 to 9.9 K |
| Sep 03 2015 | HSP | HOSPIRA INC | Endicott David J. | Pres., Hospira Medi ... | Option Exercise | M | 43.01 | 72,971 | 3,138,483 | 0 | |
| Sep 03 2015 | HSP | HOSPIRA INC | Endicott David J. | Pres., Hospira Medi ... | Sell | D | 90.00 | 205,668 | 18,510,120 | 0 | 205.7 K to 0 (-100.00 %) |